Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Coral Laboratories Limited (CORALAB.BO)

Compare
667.15
+16.75
+(2.58%)
At close: 3:50:22 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Girish Madanlal Dhameja Whole-Time Director 2.81M -- 1981
Ms. Sushma Shashi Kadkade CFO & Non-Executive Director 1.26M -- 1981
Ms. Dhwani Desai Company Secretary & Compliance Officer -- -- --

Coral Laboratories Limited

#3B, Patanwala Compound
Opp. Shreyas Cinema L.B.S. Marg, Ghatkopar (West)
Mumbai, 400086
India
91 22 2500 5245 https://corallab.com
Sector: 
Healthcare
Full Time Employees: 
142

Description

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant products, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic products, antimalarial drugs, antipsychotic drugs, thyroid, and kits, oral antiseptic preparations, mouthwashes; nutritional, protein, and iron supplements, calcium preparations, appetizers; and other products. It also offers cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Further, the company provides its products in various dosage forms, including tablets, capsules, liquid orals, liquids and powders, dry syrups, eye/ear drops, ointment and creams, gels and lotions, B-lactam, low RH facilities, granules powder, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Corporate Governance

Coral Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 21, 2025 at 10:59 AM UTC - May 26, 2025 at 12:00 PM UTC

Coral Laboratories Limited Earnings Date

Recent Events

September 20, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers